1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). This grant is for early-stage researchers to pursue projects at the intersection of engineering and the physical sciences with life sciences. It is ideal for high-risk, high-impact medical device research where preliminary data is not required.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Biomedical Imaging and Bioengineering (NIBIB)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: NIH-defined New and Early Stage Investigators at academic institutions or small businesses. Confirm the full requirements in the official notice before applying.
The current listing shows $400,000 over 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The most recent published deadline was June 16, 2026, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NIBIB Technology Development Network Coordinating Centers is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. This Notice of Funding Opportunity (NOFO) will solicit applications for NIBIB Technology Development Network Coordinating Centers. These Coordinating Centers are designed to bring scientific and engineering communities together to solve translational problems.
Funding Opportunity Announcement – NIBIB Technology Development Network Coordinating Centers (RFA‑EB‑26‑001) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Funding Opportunity Announcement for NIBIB Technology Development Network Coordinating Centers is a grant from the National Institutes of Health (NIH) through the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that will fund Coordinating Centers designed to …
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article